Concepedia

Author

Mahmoud S. Abdallah

University of Sadat CityORCID

Also Known As

Mahmoud Abdallah, Mahmoud S Abdallah, Mahmoud S. Abdallah, Mahmoud Samy Abdallah, Mahmoud Samy Abdallah

39

Publications

467

Citations

12

H-Index

25

Concepts

All Affiliations

University of Sadat CityMenoufia UniversityTanta UniversityPrincess Nourah bint Abdulrahman UniversityDamanhour University
MS

About

Mahmoud S. Abdallah is an author at University of Sadat City specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

77

2

Natural Sciences

1

1

27

3

Social Sciences

1

1

38

4

Biochemistry

1

1

27

5

Chemistry

1

1

27

Mahmoud S. Abdallah

×

13

Publications

268

Citations

11

H-Index

YearCitations

The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Sahar Mohamed El-Haggar, Mai Eissa, Tarek M. Mostafa,

Psychotherapy and Psychosomatics

2018

60

RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Mahmoud S. Abdallah, Esraa M. Mosalam, Abdel‐Aziz A. Zidan,

Neurotherapeutics

2020

38

Applying green analytical chemistry (GAC) for development of stability indicating HPLC method for determining clonazepam and its related substances in pharmaceutical formulations and calculating uncertainty

Abdallah Shalaby, Mahmoud S. Abdallah, Moataz A. Shaldam,

Arabian Journal of Chemistry

2014

27

The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial

Mahmoud S. Abdallah, Sumaiah J. Alarfaj, Dalia S. Saif,

International Immunopharmacology

2021

23

RETRACTED: The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer’s Disease-like Condition: Mechanistic Insights

Hend E. Abo Mansour, Aya Ibrahim Elberri, Mai El-Sayed Ghoneim,

Molecules

2023

19

RETRACTED: Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder

Mahmoud S. Abdallah, Ahmed Nabil Ramadan, Hend Omara‐Reda,

CNS Neuroscience & Therapeutics

2021

17

Enhanced neuroprotective effect of verapamil-loaded hyaluronic acid modified carbon quantum dots in an in-vitro model of amyloid-induced Alzheimer's disease

Esraa M. Mosalam, Hend Mohamed Abdel‐Bar, Aya Ibrahim Elberri,

International Journal of Biological Macromolecules

2024

15

Chronotherapeutic neuroprotective effect of verapamil against lipopolysaccharide-induced neuroinflammation in mice through modulation of calcium-dependent genes

Esraa M. Mosalam, Aya Ibrahim Elberri, Amany Said Sallam,

Molecular Medicine

2022

14

The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial

Mahmoud S. Abdallah, Ahmed Hossam Eldeen, Sally Said Tantawy,

European Journal of Pharmacology

2021

12

The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt

Dina Sweed, Enas Sweed, Inas Moaz,

World Journal of Surgical Oncology

2022

12

Page 1